StockData
Royalty Pharma plc logo

Royalty Pharma plc (RPRX) stock

RPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/3050% above fair value
$68.67−0.01 (-0.01%)

Close on Nov 18, 2026Market cap $39.49BP/E 39.0Yield –

Royalty Pharma market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Royalty Pharma's market cap was $39.05B on Nov 11, 2026, against $22.91B a year earlier. Over the last 5 years it ranged from $15.20B to $39.05B, with a median of $19.99B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$39.05B+76.6%
2025Dec 31, 2025$22.12B+45.4%
2024Dec 31, 2024$15.21B-4.0%
2023Dec 29, 2023$15.85B-28.8%
2022Dec 30, 2022$22.26B+0.6%
2021Dec 31, 2021$22.12B–

More Royalty Pharma figures

See a number that looks wrong?